Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
Estetrol is a natural compound that is produced by the fetus during fetal life and circulates
in the unborn child and the mother. It is an estrogenic compound. In this study the safety
and tolerability of 28 days of the oral administration of estetrol in healthy postmenopausal
women are investigated. In addition, the pharmacokinetics and some pharmacodynamic parameters
are studied. The lowest dose of 2 mg estetrol is directly compared with 2 mg estradiol.